Key differences with hypoglycaemic fear in people using insulin: the association with missed bolus doses exists for T2 D, but not T1D

Diabetologie und Stoffwechsel 2021; 16(S 01): S16-S17
DOI: 10.1055/s-0041-1727331

01. Klinische Diabetologie

SS Edwards

¹Eli Lilly and Company, Medical, Indianapolis, IN, United States

,

X He

¹Eli Lilly and Company, Medical, Indianapolis, IN, United States

,

J Johnson

¹Eli Lilly and Company, Medical, Indianapolis, IN, United States

,

ES Meadows

¹Eli Lilly and Company, Medical, Indianapolis, IN, United States

,

W Wang

¹Eli Lilly and Company, Medical, Indianapolis, IN, United States

,

H Wolpert

¹Eli Lilly and Company, Medical, Indianapolis, IN, United States

,

W Polonsky

²Behavioral Diabetes Institute, Medical, San Diego, CA, United States

,

A Ponce-Ibarra

³Lilly Deutschland GmbH, Medical, Bad Homburg, Germany